treatment of pregnant women with diethylstilbestrol ( des ) during pregnancy has been demonstrated to be associated with an increased risk in the female offspring for development of an otherwise very rare type of malignancy : clear-cell adenocarcinoma of the vagina and cervix .
C0012203
diethylstilbestrol
C0032961
pregnancy